271 results
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
to be filed or maintained, in connection with the calculation, determination, assessment or collection of any Tax and shall include any amended … such Tax Returns or pay such Taxes would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. No assessment
8-K
EX-10.2
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
or assignees thereof, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation or other
8-K
EX-99.3
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
in their assessment of segment performance and deciding how to allocate resources. Finally, ASU 2023-07 requires all segment disclosures for public entities
425
EX-10.1
ORKA
Oruka Therapeutics Inc.
15 Aug 24
Business combination disclosure
4:17pm
, customs duty, licenses tax, alternative or add-on minimum or other tax or similar charge, duty, levy, fee, tariff, impost, obligation or assessment
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
15 Aug 24
Entry into a Material Definitive Agreement
4:15pm
, customs duty, licenses tax, alternative or add-on minimum or other tax or similar charge, duty, levy, fee, tariff, impost, obligation or assessment
424B3
yd16lbhao 43padu7ox
1 Aug 24
Prospectus supplement
4:10pm
425
EX-10.2
blz407rnt3 q74j
9 Jul 24
Business combination disclosure
5:04pm
8-K
EX-10.2
lhsk3jc 91
9 Jul 24
Entry into a Material Definitive Agreement
5:01pm
425
pra quh2oi539
3 Apr 24
Business combination disclosure
7:33am
8-K
EX-2.1
wy12sz597c65 a1
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am
8-K
EX-10.2
n1v6b0s 53nuop
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am